Trials / Recruiting
RecruitingNCT05599412
Post Marketing Surveillance(PMS) Study of Lorviqua in Korea
A Prospective, Single-arm, Open-label, Non-interventional, Multi-centre, Post Marketing Surveillance (PMS) Study of Lorviqua (Registered)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to monitor the usage of Lorviqua in real practice within label, including the adverse events associated with Lorviqua
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lorviqua | As provided in real world practice |
Timeline
- Start date
- 2023-05-22
- Primary completion
- 2028-01-31
- Completion
- 2028-01-31
- First posted
- 2022-10-31
- Last updated
- 2026-03-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05599412. Inclusion in this directory is not an endorsement.